Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jincun Zhao and Stanley Perlman.
Connection Strength

7.272
  1. Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses. Immunity. 2016 06 21; 44(6):1379-91.
    View in: PubMed
    Score: 0.671
  2. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A. 2014 Apr 01; 111(13):4970-5.
    View in: PubMed
    Score: 0.574
  3. Human coronavirus EMC is not the same as severe acute respiratory syndrome coronavirus. mBio. 2013 Jan 15; 4(1).
    View in: PubMed
    Score: 0.531
  4. Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections. J Virol. 2012 Nov; 86(21):11416-24.
    View in: PubMed
    Score: 0.516
  5. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest. 2011 Dec; 121(12):4921-30.
    View in: PubMed
    Score: 0.490
  6. T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol. 2010 Sep; 84(18):9318-25.
    View in: PubMed
    Score: 0.445
  7. Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. PLoS Pathog. 2009 Oct; 5(10):e1000636.
    View in: PubMed
    Score: 0.424
  8. Severe acute respiratory syndrome coronavirus protein 6 is required for optimal replication. J Virol. 2009 Mar; 83(5):2368-73.
    View in: PubMed
    Score: 0.400
  9. Sensitization of Non-permissive Laboratory Mice to SARS-CoV-2 with a Replication-Deficient Adenovirus Expressing Human ACE2. STAR Protoc. 2020 12 18; 1(3):100169.
    View in: PubMed
    Score: 0.228
  10. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020 10 01; 130(10):5235-5244.
    View in: PubMed
    Score: 0.226
  11. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 08 06; 182(3):734-743.e5.
    View in: PubMed
    Score: 0.222
  12. Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. Sci Immunol. 2017 Aug 04; 2(14).
    View in: PubMed
    Score: 0.182
  13. Simultaneous Intranasal/Intravascular Antibody Labeling of CD4+ T Cells in Mouse Lungs. Bio Protoc. 2017 Jan 05; 7(1).
    View in: PubMed
    Score: 0.175
  14. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. mBio. 2016 12 13; 7(6).
    View in: PubMed
    Score: 0.174
  15. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016 Feb 10; 19(2):181-93.
    View in: PubMed
    Score: 0.164
  16. Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection. J Virol. 2015 Jun; 89(11):6117-20.
    View in: PubMed
    Score: 0.154
  17. Virus-specific regulatory T cells ameliorate encephalitis by repressing effector T cell functions from priming to effector stages. PLoS Pathog. 2014 Aug; 10(8):e1004279.
    View in: PubMed
    Score: 0.148
  18. T cell-mediated immune response to respiratory coronaviruses. Immunol Res. 2014 Aug; 59(1-3):118-28.
    View in: PubMed
    Score: 0.148
  19. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 2014 Oct; 88(19):11034-44.
    View in: PubMed
    Score: 0.147
  20. Development of transgenic mice expressing a coronavirus-specific public CD4 T cell receptor. J Immunol Methods. 2013 Oct 31; 396(1-2):56-64.
    View in: PubMed
    Score: 0.138
  21. IFN-?- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J Exp Med. 2011 Aug 01; 208(8):1571-7.
    View in: PubMed
    Score: 0.119
  22. Autocrine interferon priming in macrophages but not dendritic cells results in enhanced cytokine and chemokine production after coronavirus infection. mBio. 2010 Oct 19; 1(4).
    View in: PubMed
    Score: 0.114
  23. The N-terminal region of severe acute respiratory syndrome coronavirus protein 6 induces membrane rearrangement and enhances virus replication. J Virol. 2010 Apr; 84(7):3542-51.
    View in: PubMed
    Score: 0.108
  24. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease. Virology. 2010 Mar 30; 399(1):120-128.
    View in: PubMed
    Score: 0.108
  25. De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system. J Immunol. 2009 Oct 15; 183(8):5163-70.
    View in: PubMed
    Score: 0.106
  26. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Emerg Microbes Infect. 2019; 8(1):760-772.
    View in: PubMed
    Score: 0.050
  27. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia. mBio. 2018 10 30; 9(5).
    View in: PubMed
    Score: 0.050
  28. MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc Natl Acad Sci U S A. 2018 03 20; 115(12):3144-3149.
    View in: PubMed
    Score: 0.047
  29. DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice. Vaccine. 2017 04 11; 35(16):2069-2075.
    View in: PubMed
    Score: 0.044
  30. Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model. Antiviral Res. 2017 01; 137:125-130.
    View in: PubMed
    Score: 0.043
  31. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci Transl Med. 2016 Feb 17; 8(326):326ra21.
    View in: PubMed
    Score: 0.041
  32. Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4. J Infect Dis. 2016 Mar 01; 213(5):712-22.
    View in: PubMed
    Score: 0.040
  33. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 2015 Nov; 25(11):1237-49.
    View in: PubMed
    Score: 0.040
  34. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc Natl Acad Sci U S A. 2015 Aug 18; 112(33):10473-8.
    View in: PubMed
    Score: 0.040
  35. Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target. J Med Chem. 2014 Mar 27; 57(6):2247-57.
    View in: PubMed
    Score: 0.036
  36. Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J Virol. 2014 May; 88(9):4953-61.
    View in: PubMed
    Score: 0.036
  37. Crystal structure-based exploration of the important role of Arg106 in the RNA-binding domain of human coronavirus OC43 nucleocapsid protein. Biochim Biophys Acta. 2013 Jun; 1834(6):1054-62.
    View in: PubMed
    Score: 0.034
  38. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog. 2011 Oct; 7(10):e1002315.
    View in: PubMed
    Score: 0.030
  39. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol. 2011 Jan; 85(2):873-82.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.